Atezolizumab, Bevacizumab, and Tocilizumab in Advanced Hepatocellular Carcinoma
Clinical trial NCT07774247 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07774247
- Sponsor
- CHA University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-09-01
- Primary completion
- 2027-09-01
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.